Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
NextAmp™ Analysis System
2021

Share:

NextAmp™ Analysis System

Medical device

Quark Biosciences, Inc.

The NextAmp™ Analysis System is an innovative molecular diagnostic platform for precision medicine. The coffee capsule-like system is simple to use and analyzes up to 100 biomarkers in two hours. Its small physical footprint and affordability allow for use in hospitals and clinics that wouldn’t ordinarily be able to host this type of equipment. The platform’s speed and sensitivity generate quicker, more accurate, and more reliable analyses, allowing for actionable results, faster, for the patients who need it.

Date of Launch
2019
Development Time
Other duration
Target Regions
Asia, Europe, North America
Target Groups
Other target groups: Hospitals or medical testing institutions

RELATED PROJECTS